As expected, “MYC Targets V1” and “MYC Targets V2” pathways also showed increased NESs following MYC induction (Supplementary Fig. S3A), further confirming the robustness of our framework at identifying true regulators of cancer splicing factor programs. Here, MYC is linked to cancer.